According to the commission, Bidvest acquired a controlling stake in pharmaceutical group Adcock Ingram in 2014 before getting approval from competition authorities.
"In order to avoid protracted and expensive litigation, the respondents have, without admitting guilt, reached a settlement with the Competition Commission," Adcock Ingram said on Thursday.
"The settlement has been confirmed by the Competition Tribunal.
"As part of the settlement, the respondents have agreed to pay a settlement amount of R2m and to develop, implement and monitor a competition law compliance programme for senior management and directors."
Bidvest's share price fell 3.7% to R155.24 and Adcock Ingram's 2.9% to R56.77 in a generally weak day for JSE shares on Thursday.
Adcock Ingram said in its statement it "had possibly contravened section 13A(3) of the Competition Act 89 of 1998, as amended, by pre-implementation of a merger".
Source: BDpro
For more than two decades, I-Net Bridge has been one of South Africa’s preferred electronic providers of innovative solutions, data of the highest calibre, reliable platforms and excellent supporting systems. Our products include workstations, web applications and data feeds packaged with in-depth news and powerful analytical tools empowering clients to make meaningful decisions.
We pride ourselves on our wide variety of in-house skills, encompassing multiple platforms and applications. These skills enable us to not only function as a first class facility, but also design, implement and support all our client needs at a level that confirms I-Net Bridge a leader in its field.
Go to: http://www.inet.co.za
